{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:40:09Z","timestamp":1759174809958,"version":"3.44.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.diabres.2022.110014","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T22:02:52Z","timestamp":1658354572000},"page":"110014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Trends in glycemic control, cardiovascular risk factors and chronic complications of type 2 diabetes, 2012\u20132016, in a healthcare area of Barcelona"],"prefix":"10.1016","volume":"190","author":[{"given":"Irela","family":"L\u00f3pez-Cobo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llu\u00efsa","family":"Rodriguez-Latre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2891-099X","authenticated-orcid":false,"given":"Oriol","family":"Cunillera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Copetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merc\u00e8","family":"Albareda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2353-1459","authenticated-orcid":false,"given":"Llu\u00eds","family":"Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.diabres.2022.110014_b0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00125-011-2336-9","article-title":"Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study","volume":"55","author":"Soriguer","year":"2012","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.diabres.2022.110014_b0010","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10198-015-0742-5","article-title":"Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia","volume":"17","author":"Mata-Cases","year":"2016","journal-title":"Spain Eur J Heal Econ"},{"issue":"4","key":"10.1016\/j.diabres.2022.110014_b0015","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2337\/dc11-1679","article-title":"Control of Glycemia and Cardiovascular Risk Factors in Patients With Type 2 Diabetes in Primary Care in Catalonia (Spain)","volume":"35","author":"Vinagre","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110014_b0020","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2022.110014_b0025","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2022.110014_b0030","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2022.110014_b0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","article-title":"Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2022.110014_b0040","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.2337\/dc09-S339","article-title":"A Summary of the ADVANCE Trial","volume":"32","author":"Heller","year":"2009","journal-title":"Diabetes Care"},{"issue":"18","key":"10.1016\/j.diabres.2022.110014_b0045","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","article-title":"Excess Mortality among Persons with Type 2 Diabetes","volume":"373","author":"Tancredi","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.diabres.2022.110014_b0050","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1479164116637311","article-title":"Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register","volume":"13","author":"Eeg-Olofsson","year":"2016","journal-title":"Diabetes Vasc Dis Res"},{"issue":"7","key":"10.1016\/j.diabres.2022.110014_b0055","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.diabres.2022.110014_b0060","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1742-1241.2007.01367.x","article-title":"Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain","volume":"61","author":"Orozco-Beltr\u00e1n","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1016\/j.diabres.2022.110014_b0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2022.110014_b0070","first-page":"18","article-title":"Recomendaciones para el tratamiento de la diabetes mellitus tipo 2: control gluc\u00e9mico","volume":"5","author":"Alem\u00e1n","year":"2014","journal-title":"Diabetes Pr\u00e1ctica"},{"key":"10.1016\/j.diabres.2022.110014_b0075","unstructured":"Mata M, Cos F, Morros R, Diego L, Barrot J, Berengu\u00e9 M, et al. Abordatge de la Diabetis Mellitus tipus 2 2013. https:\/\/scientiasalut.gencat.cat\/bitstream\/handle\/11351\/4514\/abordatge_de_la_diabetis_mellitus_tipus_2_guies_practica_clinica_2013_versio_extensa.pdf?sequence=1&isAllowed=y (accessed April 6, 2022)."},{"key":"10.1016\/j.diabres.2022.110014_b0080","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc12-s011","article-title":"Standards of Medical Care in Diabetes\u20142012","volume":"35","author":"American Diabetes Associatrion","year":"2012","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2022.110014_b0085","doi-asserted-by":"crossref","first-page":"134.e1","DOI":"10.1016\/j.medcli.2012.10.003","article-title":"Tratamiento de la diabetes tipo 2 en el paciente anciano","volume":"140","author":"G\u00f3mez Huelgas","year":"2013","journal-title":"Med Clin (Barc)"},{"issue":"6","key":"10.1016\/j.diabres.2022.110014_b0090","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jamda.2012.04.012","article-title":"Diabetes Mellitus in Older People: Position Statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes","volume":"13","author":"Sinclair","year":"2012","journal-title":"J Am Med Dir Assoc"},{"issue":"12","key":"10.1016\/j.diabres.2022.110014_b0095","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/jgs.12035","article-title":"Diabetes in Older Adults: A Consensus Report","volume":"60","author":"Sue Kirkman","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.diabres.2022.110014_b0100","doi-asserted-by":"crossref","DOI":"10.5334\/ijic.5496","article-title":"Clustering Complex Chronic Patients: A Cross-Sectional Community Study From the General Practitioner\u2019s Perspective","volume":"21","author":"Hernansanz Iglesias","year":"2021","journal-title":"Int J Integr Care"},{"issue":"10","key":"10.1016\/j.diabres.2022.110014_b0105","doi-asserted-by":"crossref","first-page":"e012463","DOI":"10.1136\/bmjopen-2016-012463","article-title":"Glycaemic control and antidiabetic treatment trends in primary care centres in patients with type 2 diabetes mellitus during 2007\u20132013 in Catalonia: a population-based study","volume":"6","author":"Mata-Cases","year":"2016","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.diabres.2022.110014_b0110","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s13300-017-0280-5","article-title":"Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014","volume":"8","author":"Carls","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2022.110014_b0115","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc12-2258","article-title":"The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988\u20132010","volume":"36","author":"Stark Casagrande","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110014_b0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12902-016-0090-1","article-title":"Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain","volume":"16","author":"Mi\u00f1ambres","year":"2016","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"10.1016\/j.diabres.2022.110014_b0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0145721715619038","article-title":"Medication Adherence With Diabetes Medication","volume":"42","author":"Capoccia","year":"2016","journal-title":"Diabetes Educ"},{"issue":"17","key":"10.1016\/j.diabres.2022.110014_b0130","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMsa1213829","article-title":"Achievement of Goals in U.S. Diabetes Care, 1999\u20132010","volume":"368","author":"Ali","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.diabres.2022.110014_b0135","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/2047487315569401","article-title":"EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries","volume":"23","author":"Kotseva","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"10.1016\/j.diabres.2022.110014_b0140","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"10.1016\/j.diabres.2022.110014_b0145","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/dom.13625","article-title":"Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry","volume":"21","author":"Fan","year":"2019","journal-title":"Diabetes, Obes Metab"},{"key":"10.1016\/j.diabres.2022.110014_b0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1475-9276-13-43","article-title":"Inequalities in health care among patients with type 2 diabetes by individual socio-economic status (SES) and regional deprivation: a systematic literature review","volume":"13","author":"Grintsova","year":"2014","journal-title":"Int J Equity Health"},{"issue":"1","key":"10.1016\/j.diabres.2022.110014_b0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-018-5269-0","article-title":"Socioeconomic inequalities in cardiometabolic control in patients with type 2 diabetes","volume":"18","author":"Ib\u00e1\u00f1ez","year":"2018","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.diabres.2022.110014_b0160","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.pcd.2021.02.003","article-title":"Evaluation of clinical and antidiabetic treatment characteristics of different sub-groups of patients with type 2 diabetes: Data from a Mediterranean population database","volume":"15","author":"Mata-Cases","year":"2021","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.diabres.2022.110014_b0165","unstructured":"Fau E, Mata M, Mena D, Morros R, Pellicer M, Ricart W, et al. Pautes per a l\u2019harmonitzaci\u00f3 del tractament farmacol\u00f2gic de la diabetis mellitus tipus 2 2019. https:\/\/catsalut.gencat.cat\/web\/.content\/minisite\/catsalut\/proveidors_professionals\/medicaments_farmacia\/harmonitzacio\/pautes\/diabetis-mellitus-tipus2\/pauta-harmonitzacio-diabetis-mellitus-tipus2.pdf (accessed April 1, 2022)."},{"key":"10.1016\/j.diabres.2022.110014_b0170","doi-asserted-by":"crossref","unstructured":"Hampp C, Borders-Hemphill V, Moeny DG, Wysowski DK. Use of Antidiabetic Drugs in the U.S., 2003\u20132012. Diabetes Care 2014;37:1367\u201374. https:\/\/doi.org\/10.2337\/dc13-2289.","DOI":"10.2337\/dc13-2289"},{"issue":"4","key":"10.1016\/j.diabres.2022.110014_b0175","doi-asserted-by":"crossref","first-page":"e13080","DOI":"10.1111\/ijcp.13080","article-title":"The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016\/17","volume":"72","author":"Heald","year":"2018","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.diabres.2022.110014_b0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.diabres.2014.12.007","article-title":"Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: A population-based study","volume":"108","author":"Rafaniello","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.diabres.2022.110014_b0185","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11845-013-1011-1","article-title":"Prescribing of antidiabetic therapies in Ireland: 10-year trends 2003\u20132012","volume":"183","author":"Zaharan","year":"2014","journal-title":"Ir J Med Sci"},{"issue":"4","key":"10.1016\/j.diabres.2022.110014_b0190","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.clinthera.2017.02.008","article-title":"Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study","volume":"39","author":"Overbeek","year":"2017","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.diabres.2022.110014_b0195","doi-asserted-by":"crossref","first-page":"e000093","DOI":"10.1136\/bmjdrc-2015-000093","article-title":"Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system","volume":"3","author":"Pantalone","year":"2015","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"10.1016\/j.diabres.2022.110014_b0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/02813432.2022.2036458","article-title":"Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study","volume":"40","author":"Mikkola","year":"2022","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.diabres.2022.110014_b0205","unstructured":"Fau E, Mata M, Morros R, Pellicer M\u00c0, Ricard W, Vall\u00e8s J-A, et al. Pautes per a l\u2019harmonitzaci\u00f3 del tractament farmacol\u00f2gic de la diabetis mellitus tipus 2. Scientia 2013. https:\/\/scientiasalut.gencat.cat\/bitstream\/handle\/11351\/1403\/pautes_tractament_farmacologic_diabetis_mellitus_tipus2_2013.pdf?sequence=1&isAllowed=y (accessed April 29, 2022)."},{"issue":"1","key":"10.1016\/j.diabres.2022.110014_b0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pcd.2016.09.003","article-title":"Clinical inertia to insulin initiation and intensification in the UK: A focused literature review","volume":"11","author":"Khunti","year":"2017","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.diabres.2022.110014_b0215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/dom.13045","article-title":"Therapeutic inertia in patients treated with two or more antidiabetics in primary care: <scp>F<\/scp> actors predicting intensification of treatment","volume":"20","author":"Mata-Cases","year":"2018","journal-title":"Diabetes, Obes Metab"},{"key":"10.1016\/j.diabres.2022.110014_b0220","unstructured":"WHO. Adherence to long term therapies. Evidence for action 2013:71\u201385. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/42682\/9241545992.pdf;jsessionid=181FF135C2B0B2C3EADEFB1EAEE4C344?sequence=1 (accessed April 1, 2022)."},{"issue":"7","key":"10.1016\/j.diabres.2022.110014_b0225","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1185\/03007995.2015.1053048","article-title":"Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes","volume":"31","author":"Iglay","year":"2015","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.diabres.2022.110014_b0230","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2337\/dc18-1453","article-title":"Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes","volume":"42","author":"Patel","year":"2019","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2022.110014_b0235","doi-asserted-by":"crossref","first-page":"e2036725","DOI":"10.1001\/jamanetworkopen.2020.36725","article-title":"Assessment of Interprofessional Collaborative Practices and Outcomes in Adults With Diabetes and Hypertension in Primary Care","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:23:41Z","timestamp":1759173821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722008282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":47,"alternative-id":["S0168822722008282"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110014","relation":{},"ISSN":["0168-8227"],"issn-type":[{"type":"print","value":"0168-8227"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in glycemic control, cardiovascular risk factors and chronic complications of type 2 diabetes, 2012\u20132016, in a healthcare area of Barcelona","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110014"}}